Can we prevent age-related cognitive decline, and perhaps even head off Alzheimer’s disease and related dementias before they start? Pharmaceutical…
In 1987, lovastatin became the first FDA-approved statin in the United States. Four decades later, statins are among the most…
When you think of palliative care pharmacotherapy, you probably think about the tried-and-true mainstays of our field like morphine, haloperidol,…
Love the story Judy Solerno tells at the start of this podcast. The story is about how John Snow, the…
Just in time for respiratory virus season, this episode of the podcast breaks down essential vaccine guidance for older adults…
Difficulty managing money is often one of the earliest signs of Alzheimer’s disease and related dementias, frequently appearing years before…
GLP-1 receptor agonists (the “Ozempics of the world”) have been a truly revolutionary pharmacological advance in modern medicine. In randomized…
As Diane Meier remarks to start today’s podcast, palliative care has come a long way from the days when we…
Up until just a couple years ago, an 85-year-old patient presenting with gradual, amnestic memory loss was almost automatically presumed…
Can simple, evidence-based video decision aids—paired with structured clinician training—improve Advance Care Planning (ACP) documentation and goal-concordant care? That’s the…